Cargando…

Proceedings: BCG immunotherapy: its interest in association with radiotherapy in the treatment of Lewis tumour in mice.

Detalles Bibliográficos
Autores principales:	Dubois, J. B., Serrou, B., Pourquier, H.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1975
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025047/ https://www.ncbi.nlm.nih.gov/pubmed/1220792

Ejemplares similares

Proceedings: B.C.G. treatment of pleural and peritoneal tumour growth in rats.
por: Pimm, M. V.
Publicado: (1974)

Proceedings: Role of immunocompetence in localized BCG suppression of tumour growth.
por: Pimm, M. V., et al.
Publicado: (1975)

Proceedings: Tumour therapy in dogs using B.C.G.
por: Owen, L. N., et al.
Publicado: (1974)

Immunotherapy of primary methylcholanthrene-induced mouse tumours by intratumoral BCG.
por: Creau-Goldberg, N., et al.
Publicado: (1980)

BCG treatment of human tumour xenografts in athymic nude mice.
por: Pimm, M. V., et al.
Publicado: (1978)

BCG Immunotherapy of Pulmonary Growths from Intravenously Transferred Rat Tumour Cells
por: Baldwin, R. W., et al.
Publicado: (1973)

BCG immunotherapy of rat sarcomata.
por: Baldwin, R. W., et al.
Publicado: (1973)

BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020)

BCG Immunotherapy of a Rat Sarcoma
por: Baldwin, R. W., et al.
Publicado: (1973)

Bladder Cancer Immunotherapy: BCG and Beyond
por: Askeland, Eric J., et al.
Publicado: (2012)

Reparameterized multiobjective control of BCG immunotherapy
por: Yue, Rongting, et al.
Publicado: (2023)

Methanol extraction residue of BCG in the treatment of transplanted rat tumours.
por: Hopper, D. G., et al.
Publicado: (1975)

Immunotherapy as sensitizer for local radiotherapy
por: Vanneste, Ben G.L., et al.
Publicado: (2020)

Proceedings: Some aspects of the use of B.C.G. in the treatment of advanced malignant disease.
por: Grant, R. M., et al.
Publicado: (1974)

Distant metastasis facilitated by BCG: spread of tumour cells injected in the BCG-primed site.
por: Ishibashi, T., et al.
Publicado: (1980)

Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy
por: Lima, L, et al.
Publicado: (2013)

Proceedings: Maintenance of human tumours in immune deficient mice.
por: Franks, C. R., et al.
Publicado: (1975)

Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy
por: Rao, Manoj V., et al.
Publicado: (2013)

Systemic Bacillus Calmette-Guérin (BCG) Infection With Renal Involvement: A Rare Complication of BCG Immunotherapy
por: Afonso, Raquel, et al.
Publicado: (2022)

An uncommon cause of miliary disease: intravesical BCG immunotherapy
por: Azevedo, Marcelo, et al.
Publicado: (2021)

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6(th) annual ImmunoRad conference
por: Gregucci, Fabiana, et al.
Publicado: (2023)

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
por: Bevers, R F M, et al.
Publicado: (2004)

Bladder Sparing Therapy for BCG Failures – I – Intravesical Immunotherapy
por: Messing, Edward M.
Publicado: (2017)

Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group
por: D'Antonio, Fabrizia, et al.
Publicado: (2021)

Systemic Bacillus Calmette-Guérin (BCG) Infection and Accompanying Warm Autoimmune Haemolytic Anaemia Following Intravesical BCG Immunotherapy
por: Güven, Alper Tuna, et al.
Publicado: (2023)

Reduction of tumour cell entry into vessels by BCG-activated macrophages.
por: Liotta, L. A., et al.
Publicado: (1977)

Does restaging transurethral resection of bladder tumour influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience
por: Krajewski, Wojciech, et al.
Publicado: (2018)

An Interesting Case of Cerebral Tumour
por: Macdonald, D. M.
Publicado: (1908)

Proceedings: Host immune responses in B.C.G. therapy of a rat osteosarcoma.
por: Lawrence, N., et al.
Publicado: (1974)

Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting
por: Goldman, Jennifer G., et al.
Publicado: (2021)

DNA Content of Human Tumours: Change in Uterine Tumours During Radiotherapy and their Response to Treatment
por: Richards, B. M., et al.
Publicado: (1959)

Effectiveness of BCG vaccination to aged mice
por: Ito, Tsukasa, et al.
Publicado: (2010)

Genome sequences of BCG Pasteur ATCC 35734 and its derivative, the vaccine candidate BCGΔBCG1419c
por: D’Auria, Giuseppe, et al.
Publicado: (2023)

Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.
por: Stanley, J. A., et al.
Publicado: (1977)

Dexamethasone and radiation response in the Lewis lung tumour model.
por: Agboola, O. O., et al.
Publicado: (1983)

Renal Tuberculosis Following Intravesical Bacillus Calmette–Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer
por: Bajramovic, Senad, et al.
Publicado: (2020)

The Relationship of Immune Status to the Efficacy of Immunotherapy in Preventing Tumour Recurrence in Mice
por: Levy, J. G., et al.
Publicado: (1974)

Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975)

Significance of cytotoxic lymphocytes after various immunizing procedures in a virus-induced non-producer syngeneic system: correlation between in vitro and in vivo lytic activity.
por: Pioch, Y., et al.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_dka0h9nkljpc4hdd6crdr1lgjs